Special Series in Celebration of KBR’s 3rd Anniversary < Special < 기사목록

상단영역

UPDATE : 2022-05-17 18:06 (Tue)

Home Log in Join

기사검색

Recent News

Photo News

Most Viewed

Important: Subvariants’ continuous appearances thwart Korea’s hope for early end to Covid-19

Yonsei researchers find new targeted therapy for endometrial cancer, multiple myeloma

Triferic registered in patented drugs, Jeil to sell it exclusively in Korea

Will Yoon government raise Covid’s classification back to Class 1?

Celltrion sends trial plans for global P3 study for Actemra biosimilar

Coreline Soft to supply AI chest diagnostic solution to Germany, Belgium

[Interview with Global Pharma Leaders] 'Merck Biopharma Korea focusing on rare disease patients neglected due to small numbers'

‘Virtual communication will help Korean medical societies go global’

Government to use real-world data to study safety of Covid-19 vaccines, treatments

Amid dwindling Covid-19 cases at home, President Yoon repeats offer to help North's pandemic battle

Doctors should ask about their patient’s ‘occupation.’ Why?

KAIST develops nanoparticles to dissolve Alzheimer’s-causing substance

Latest: State research organ identifies treatment mechanisms for PTSD

Government hints at lifting Covid-19 controls after 2 weeks

SNUBH, GE Healthcare to build platform to support medical AI startups

Korea to halt vaccine mandate from March

Bayer seeks to add indications for Nubeqa in treating mHSPC

Health minister denies relationship between eased curbs and presidential election

Hematopoietic stem cell transplants from haploidentical related donors prove effective

Seegene develops reagent detecting Covid-19 infection in 30 minutes

SK Biopharm soon to begin phase 3 cenobamate trial in Asia

Myongji Hospital transfers infectious disease responding know-how to foreign doctors

LG Chem, PCL to sell Covid-19 antigen test kit for professional use

OCI becomes largest stakeholder in Bukwang Pharm